Daniel H. Orenstein, General Counsel at Health Catalyst, Inc. (HCAT), sold 2,838 shares at $14.85 ($42K) on 2022-06-06, disclosed to the SEC on 2022-06-08.
Scheduled sale ($42k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HCAT | SELL | 2021-12-07 | $421K | — | Filing → |
| HCAT | SELL | 2021-11-02 | $260K | — | Filing → |
| HCAT | SELL | 2021-10-05 | $123K | — | Filing → |